(no title)
mockingbirdy | 1 month ago
paper: https://pubmed.ncbi.nlm.nih.gov/29857928/
short: We have a rigorously validated antigen-specific immune tolerance platform with bystander suppression, NIH/MS Society backing and a clear translational gap.
mockingbirdy | 1 month ago
paper: https://pubmed.ncbi.nlm.nih.gov/29857928/
short: We have a rigorously validated antigen-specific immune tolerance platform with bystander suppression, NIH/MS Society backing and a clear translational gap.
No comments yet.